Astrana Health (NASDAQ:ASTH) Hits New 12-Month Low - What's Next?

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) shares reached a new 52-week low on Monday . The company traded as low as $31.20 and last traded at $31.35, with a volume of 194714 shares traded. The stock had previously closed at $32.18.

Wall Street Analyst Weigh In

Several analysts have recently commented on ASTH shares. TD Cowen assumed coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price objective on the stock. BTIG Research boosted their price target on Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a report on Thursday, October 3rd. KeyCorp assumed coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a "sector weight" rating on the stock. Robert W. Baird increased their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. Finally, Macquarie raised Astrana Health to a "hold" rating in a report on Monday, December 16th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Astrana Health currently has a consensus rating of "Moderate Buy" and an average price target of $65.17.

Astrana Health Stock Down 2.3 %

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a fifty day moving average of $41.46 and a two-hundred day moving average of $47.31. The company has a market cap of $1.77 billion, a PE ratio of 24.18, a price-to-earnings-growth ratio of 1.80 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period in the prior year, the company posted $0.47 EPS. As a group, analysts anticipate that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

A number of hedge funds and other institutional investors have recently bought and sold shares of ASTH. GAMMA Investing LLC bought a new position in shares of Astrana Health in the third quarter worth about $34,000. Nisa Investment Advisors LLC bought a new position in Astrana Health in the 3rd quarter worth about $35,000. KBC Group NV purchased a new position in shares of Astrana Health during the third quarter worth approximately $70,000. Quarry LP bought a new stake in shares of Astrana Health during the third quarter valued at approximately $77,000. Finally, Quest Partners LLC purchased a new stake in shares of Astrana Health in the third quarter valued at approximately $133,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.